Obalon Therapeutics Inc (NASDAQ:OBLN) on Focus After Report of More Shorts

October 11, 2018 - By Adrian Erickson

The stock of Obalon Therapeutics Inc (NASDAQ:OBLN) registered an increase of 12.47% in short interest. OBLN’s total short interest was 804,800 shares in October as published by FINRA. Its up 12.47% from 715,600 shares, reported previously. With 454,600 shares average volume, it will take short sellers 2 days to cover their OBLN’s short positions. The short interest to Obalon Therapeutics Inc’s float is 12.54%.

The stock decreased 0.49% or $0.0111 during the last trading session, reaching $2.2589. About 2,401 shares traded. Obalon Therapeutics, Inc. (NASDAQ:OBLN) has declined 65.10% since October 11, 2017 and is downtrending. It has underperformed by 80.72% the S&P500.

Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The company has market cap of $51.01 million. It offers the Obalon balloon system designed to provide weight loss in obese patients. It currently has negative earnings.

More recent Obalon Therapeutics, Inc. (NASDAQ:OBLN) news were published by: Benzinga.com which released: “36 Stocks Moving In Tuesday’s Mid-Day Session” on October 09, 2018. Also Globenewswire.com published the news titled: “Daina Schmidt Joins Obalon Therapeutics As Vice President, Marketing” on October 09, 2018. Benzinga.com‘s news article titled: “46 Biggest Movers From Yesterday” with publication date: October 10, 2018 was also an interesting one.

Obalon Therapeutics, Inc. (NASDAQ:OBLN) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News